{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:25:01Z","timestamp":1790270701491,"version":"4.1.0"},"reference-count":41,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1135285"],"award-info":[{"award-number":["APP1135285"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1137127"],"award-info":[{"award-number":["APP1137127"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1150989"],"award-info":[{"award-number":["APP1150989"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004365","name":"Sydney Medical School","doi-asserted-by":"publisher","award":["Summer Scholarship"],"award-info":[{"award-number":["Summer Scholarship"]}],"id":[{"id":"10.13039\/501100004365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","award":["Robinson Fellowship"],"award-info":[{"award-number":["Robinson Fellowship"]}],"id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,2,1]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) in clinical quality registries, for people with cutaneous melanoma, to inform a new Australian Melanoma Clinical Outcomes Registry; and describe opportunities and challenges of routine PROM\/PREM collection, especially in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Which PROMs and PREMs are used in clinical quality registries for people with cutaneous melanoma, how they are collected, frequency of collection, participant recruitment methods and funding models for each registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1134 studies were identified from MEDLINE, PreMEDLINE, Embase, PsychInfo, Cochrane Database of Abstracts of Reviews of Effects databases and TUFTS Cost-Effectiveness Analysis Registry, alongside grey literature, from database inception to 5th February 2020. Following screening, 14 studies were included, identifying four relevant registries: Dutch Melanoma Registry, Adelphi Real-World Disease-Specific Programme (Melanoma), Patient-Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship Registry, and Cancer Experience Registry. These used seven PROMs: EuroQol-5 Dimensions, Functional Assessment of Cancer-General (FACT-G) and FACT-Melanoma (FACT-M), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Cancer 30 (EORTC QLQ-C30), Fatigue Assessment Scale Hospital Anxiety and Depression Scale, Patient-Reported Outcome Measures Information System-29 and one PREM; EORTC QLQ-Information Module 26. PROMs\/PREMs in registries were reported to improve transparency of care; facilitate clinical auditing for quality assessment; enable cost-effectiveness analyses and create large-scale research platforms. Challenges included resource burden for data entry and potential collection bias toward younger, more affluent respondents. Feedback from patients with melanoma highlighted the relevance of PROMs\/PREMs in assessing patient outcomes and patient experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinical registries indicate PROMs\/PREMs for melanoma care can be incorporated and address important gaps, however cost and collection bias may limit generalisability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42018086737.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-040751","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T11:59:14Z","timestamp":1613044754000},"page":"e040751","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review"],"prefix":"10.1136","volume":"11","author":[{"given":"Zachary","family":"Blood","sequence":"first","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Tran","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Caleo","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Saw","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, North Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbathio","family":"Dieng","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-4655","authenticated-orcid":false,"given":"Mark","family":"Shackleton","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Peter","family":"Soyer","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, Dermatology Research Centre, The University of Queensland, Saint Lucia, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Arnold","sequence":"additional","affiliation":[{"name":"Skin Health Institute, Melbourne, Victoria, Australia"},{"name":"BioGrid Australia, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J","family":"Mann","sequence":"additional","affiliation":[{"name":"Western Clinical School, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-0572","authenticated-orcid":false,"given":"Rachael L","family":"Morton","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"2025121601140705000_11.2.e040751.1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-008-9396-4"},{"key":"2025121601140705000_11.2.e040751.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2013-002707"},{"key":"2025121601140705000_11.2.e040751.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f167"},{"key":"2025121601140705000_11.2.e040751.4","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgm002"},{"key":"2025121601140705000_11.2.e040751.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-1981-1","article-title":"Study protocol of an equivalence randomized controlled trial to evaluate the effectiveness of three different approaches to collecting patient reported outcome measures (PROMs) data using the prostate cancer outcomes Registry-Victoria (PCOR-VIC)","volume":"17","author":"Hoque","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025121601140705000_11.2.e040751.6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1754-9485.12699","article-title":"Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy","volume":"62","author":"Ong","year":"2018","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2025121601140705000_11.2.e040751.7","doi-asserted-by":"crossref","unstructured":"Ong WL , Evans SM , Evans M , et al . Trends in conservative management for low-risk prostate cancer in a population-based cohort of Australian men diagnosed between 2009 and 2016. Eur Urol Oncol 2019;74.doi:10.1016\/j.euo.2019.04.006","DOI":"10.1016\/j.euo.2019.04.006"},{"key":"2025121601140705000_11.2.e040751.8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamadermatol.2013.9852","article-title":"Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2025121601140705000_11.2.e040751.9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"2025121601140705000_11.2.e040751.10","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/ajd.12323","article-title":"Patient experiences and outcomes following facial skin cancer surgery: a qualitative study","volume":"57","author":"Lee","year":"2016","journal-title":"Australas J Dermatol"},{"key":"2025121601140705000_11.2.e040751.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2025121601140705000_11.2.e040751.12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.9561","article-title":"Humanistic burden of disease in earlier stage metastatic (stage IIIb\/c-IVM1a) versus late stage metastatic (IVM1b\/c) melanoma patients in a real-world setting in the U.S","volume":"35","author":"Buchanan","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025121601140705000_11.2.e040751.13","first-page":"21","article-title":"Elevating the patient voice: innovative strategies for improving patient-centered care through qualitative and quantitative systems of reporting patient experiences of underserved populations","volume":"25","author":"Buzaglo","year":"2016","journal-title":"Pscyho-oncology"},{"key":"2025121601140705000_11.2.e040751.14","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.9588","article-title":"Financial toxicity and cancer-related distress among melanoma survivors","volume":"35","author":"Buzaglo","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025121601140705000_11.2.e040751.15","doi-asserted-by":"crossref","first-page":"A456","DOI":"10.1016\/j.jval.2017.08.327","article-title":"Health-Related quality of life in oncology \u2013 are we getting better?","volume":"20","author":"Byrne","year":"2017","journal-title":"Value in Health"},{"key":"2025121601140705000_11.2.e040751.16","doi-asserted-by":"crossref","first-page":"A456","DOI":"10.1016\/j.jval.2017.08.325","article-title":"Are there differences in Fact-G scores between different tumour types for an EU population using real world data?","volume":"20","author":"Hallworth","year":"2017","journal-title":"Value in Health"},{"key":"2025121601140705000_11.2.e040751.17","article-title":"Core cancer outcomes from the population-based profiles registry","volume":"10","author":"Horevoorts","year":"2017","journal-title":"J Evid Based Med"},{"key":"2025121601140705000_11.2.e040751.18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/0284186X.2016.1267398","article-title":"Cancer survivors' preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry","volume":"56","author":"Huibertse","year":"2017","journal-title":"Acta Oncol"},{"key":"2025121601140705000_11.2.e040751.19","article-title":"Independent prognostic value of the EORTC QLQ-C30 summary score on all-cause mortality: results from the population-based profiles registry","volume":"36(15_suppl)","author":"dRB","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025121601140705000_11.2.e040751.20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejca.2016.11.021","article-title":"Dutch melanoma treatment registry: quality assurance in the care of patients with metastatic melanoma in the Netherlands","volume":"72","author":"Jochems","year":"2017","journal-title":"Eur J Cancer"},{"key":"2025121601140705000_11.2.e040751.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.030"},{"key":"2025121601140705000_11.2.e040751.22","doi-asserted-by":"crossref","first-page":"v518","DOI":"10.1093\/annonc\/mdx385.022","article-title":"Generating patient reported outcome norms for an EU cancer population using real world data (FACT-G)","volume":"28","author":"Rider","year":"2017","journal-title":"Annals of Oncology"},{"key":"2025121601140705000_11.2.e040751.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.04.034"},{"key":"2025121601140705000_11.2.e040751.24","first-page":"343","article-title":"Fear of recurrence in cancer survivors: a study from the population-based profiles registry","volume":"23","author":"van de Wal","year":"2014","journal-title":"Psycho-Oncology"},{"key":"2025121601140705000_11.2.e040751.25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pon.4002","article-title":"Does fear of cancer recurrence differ between cancer types? A study from the population-based profiles registry","volume":"25","author":"van de Wal","year":"2016","journal-title":"Psychooncology"},{"key":"2025121601140705000_11.2.e040751.26","doi-asserted-by":"publisher","DOI":"10.1177\/0163278705275341"},{"key":"2025121601140705000_11.2.e040751.27","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23424"},{"key":"2025121601140705000_11.2.e040751.28","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802457040"},{"key":"2025121601140705000_11.2.e040751.29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2025121601140705000_11.2.e040751.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00392-6"},{"key":"2025121601140705000_11.2.e040751.31","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-29"},{"key":"2025121601140705000_11.2.e040751.32","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1047"},{"key":"2025121601140705000_11.2.e040751.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.011"},{"key":"2025121601140705000_11.2.e040751.34","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/dam039"},{"key":"2025121601140705000_11.2.e040751.35","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e29"},{"key":"2025121601140705000_11.2.e040751.36","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-006-9157-1"},{"key":"2025121601140705000_11.2.e040751.37","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9.1.e2"},{"key":"2025121601140705000_11.2.e040751.38","unstructured":"Morton RL DK , RPM S , Bartula I . ePROMs-MEL. ANZCTR study registration ACTRN12620001149954 2020."},{"key":"2025121601140705000_11.2.e040751.39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CMR.0b013e32835e5932","article-title":"What are the pertinent quality-of-life issues for melanoma cancer patients? aiming for the development of a new module to accompany the EORTC core questionnaire","volume":"23","author":"Winstanley","year":"2013","journal-title":"Melanoma Res"},{"key":"2025121601140705000_11.2.e040751.40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/pon.5251","article-title":"Development of the melanoma concerns questionnaire (MCQ-28); refinement of the EORTC QLQ-MEL38 module","volume":"29","author":"Winstanley","year":"2020","journal-title":"Psychooncology"},{"key":"2025121601140705000_11.2.e040751.41","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1200\/JCO.2018.36.15_suppl.10070","article-title":"Independent prognostic value of the EORTC QLQ-C30 summary score on all-cause mortality: results from the population-based profiles registry","volume":"36","author":"Husson","year":"2018","journal-title":"Journal of Clinical Oncology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-040751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:14:15Z","timestamp":1765876455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-040751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,11]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bmjopen-2020-040751"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-040751","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}